chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a patient of unknown age. ON 13-JAN-2014 the patient was vaccinated with one dose of M-M-R II (dose not reported, lot # reported as J003005, expired date: 14-MAR-2014) (unspecified in series) that was improperly stored with exposure to 9C for up to 64 hours. They were not standard doses. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Took J&J Vaccine Saturday Not allowed to get out of your car for five minutes because of potential sides. Not allowed to drive away for 20 minutes because of potential sides. 12 hours later, Saturday night, I'm driving along, and my body starts to shut down with chills, aches, and flu-like symptoms. Sunday evening, I'm just meh, and feel slightly better. Monday laying on the couch, not horrible but not great. Tuesday night rolls around, and I'm taken out yet again with 'flu-like symptoms. Wednesday, my flu-like symptoms hitting me hard.  Currently popping Asprin and Theraflu and am ready to call it a night yet again.
After administration OF Tdap & MCV4 c/ of left jaw pain and rash. Also low pitch wheeze
pt was given DTP/OPV/HIB 16JUN92 pt went home & mom states went to bed; pt woke up lt leg was swollen & painful to walk on; mom called us & asked what to do; sent to ER;
High BP and Chest Pain. Very high BP for the first 30 days reaching 185/118 on a regular basis. Frequency of events an pain diminished after 60 days
No additional AE reported; following a temperature excursion; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 11-OCT-2021, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # T022294 was confirmed to be valid, with expiration date 26-MAR-2022 (dose, route of administration, vaccination site were not specified) for prophylaxis. The temperature excursion was 52 degrees Fahrenheit (F) for 62 hours. There were no previous excursions reported. No adverse effects were reported.
About four hours after receiving my second dose, I became very lethargic and my body acted all over. I began having a low grade fever which I took Tylenol for. Side effects overall lasted about 36 hours.
patient call at 6 pm tonight to let me know she was having side effects from a covid vaccine given last Saturday, she is having headaches, nausea and rapid heart rate.  She had contacted her physician and is feeling better today but called to let me know she didn't think she wanted to get the second shot.  I told her I was sorry she was having side effects and told her I would report the side effects with vaers.  I will fill out an vaers tonight.  She was feeling better and did not ask for anything else to be done.
lost strings in her arm; sore arm had redness 8.5 in long and 3in wide and extend to back down her shoulder; minor sore on the day of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (minor sore on the day of injection), ERYTHEMA (sore arm had redness 8.5 in long and 3in wide and extend to back down her shoulder) and LIMB DISCOMFORT (lost strings in her arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (minor sore on the day of injection). On 08-Feb-2021, the patient experienced ERYTHEMA (sore arm had redness 8.5 in long and 3in wide and extend to back down her shoulder). On an unknown date, the patient experienced LIMB DISCOMFORT (lost strings in her arm). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (minor sore on the day of injection), ERYTHEMA (sore arm had redness 8.5 in long and 3in wide and extend to back down her shoulder) and LIMB DISCOMFORT (lost strings in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Information has been received from a currently 64 year old female patient referring to herself. No pertinent or historical conditions were reported. On an unknown date in 2009 (reported as when the patient was 58 year old), the patient was vaccinated with ZOSTAVAX (strength, dose and route unknown), she was given the vaccine before it was indicated for people less than 60 years of age (Inappropriate Schedule of Drug Administration). There was no concomitant medication reported. No adverse event was reported. Additional information is not expected.
Patient had redness/swelling below the injection site.  Upper arm area was warm to the touch.  Patient went to local ER and was worked up for clot/bleeding and was found to not have a clot.
Child in clinic 6-20-08 for well exam and vaccines - record from medical center states DTAP given not TDAP, CDC contacted - stated UTD no need to re-vaccinated - but should report to VAERS.
night sweats; fatigue; low grade fever; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (low grade fever), NIGHT SWEATS (night sweats) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 08-Mar-2021, the patient experienced PYREXIA (low grade fever). On 16-Apr-2021, the patient experienced FATIGUE (fatigue). On an unknown date, the patient experienced NIGHT SWEATS (night sweats). On 08-Mar-2021, PYREXIA (low grade fever) had resolved. At the time of the report, NIGHT SWEATS (night sweats) had not resolved and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treated with IBUPROFEN.
None. Pt given Adult Hep B instead of pediatric Hep B. There was no adverse event: This was a 17 year old getting an adult dose of Hep B. No adverse event noted.
This case was reported by an unknown source and described the occurrence of sensitivity to latex in an unknown number of subjects of unspecified ages and gender who were vaccinated with FLUARIX, (GlaxoSmithKline).  On unspecified dates, the subject received a dose of FLUARIX (unknown).  At unspecified times after vaccination with FLUARIX, the subject experienced sensitivity to latex.  A pharmacist reported via sales representative that he was seeing a higher incidence of reactions in subjects receiving FLUARIX compared to other Flu vaccines.  No specific number reported and no individual information provided.  At the time of reporting the outcome of the event was unspecified.
Patient presented to the ED on 3/7/21 and was subsequently hospitalized with A-fib with RVR. Patient was also hospitalized on 4/6/21 with pseudoaneurysm following procedure. These visits occurred within 6 weeks of receiving COVID vaccination.
The pt developed a fever of 104 deg F and rash (fine red on body). Seen physician and temp lasted for three days.
No other adverse event; Vaccines were administered following a temperature excursion.; This spontaneous report was received from a state vaccine coordinator regarding a 6-month-old patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 27-SEP-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #W004501, expiration date: 20-APR-2023, taken orally (strength was not provided) as prophylaxis (Product storage error).  The improperly stored vaccine underwent a temperature excursion of 8.6 degrees Celsius (C) for 18 minutes with previous excursions of 11.5C for 1 hour and 6 minutes; 8.8C for 21 minutes; and 9.6C for 6 hours and 41 minutes. No adverse events were reported.  This is one of nine cases received from the same reporter.; Sender's Comments:  US-009507513-2209USA010833: US-009507513-2209USA010884: US-009507513-2209USA010940: US-009507513-2209USA010983: US-009507513-2209USA010910: US-009507513-2209USA010935: US-009507513-2209USA010872:
After the vaccine about 3 days later I was in severe pain, and I had urinary retraction. I went to the ER and they put me on morphine and a catheter. They sent me home from the ER with a Catheter, I saw my urologist and an OBGYN and had a full hysterectomy. I had a radical hysterotomy and I'm still recovering.
Narrative:  75yo pt with h/o dementia in Hospice care died on 8/13/2021. Pt had received covid vaccines from local grocery store pharmacy on 3/1/21 & 3/29/21. Pt had outside medical and pharmacy providers. Pt's Problem List: R69. Benign prostatic hypertrophy (SCT 266569009) J84.112 Idiopathic pulmonary fibrosis (SCT 700250006) E78.5 Hyperlipidemia (SCT 55822004) F03.90 Dementia (SCT 52448006) R73.9 Hyperglycemia (SCT 80394007) R91.1 Solitary nodule of lung (SCT 427359005) I10. Hypertension (SCT 38341003) I67.9 Stroke (SCT 230690007) This death is likely not related to the vaccinations due to other comorbidities, age, and length of time from vaccine administration.
Hacking cough for 2 days, then added running nose, then added head conjestion  Taking Lagevrio 200 mg 4 capsules every 12 hours and Benzonatate 200mg 1 capsule 3 x a day
Within 12-24 hrs, pt developed hives all over body after receiving Tdap.
Death; This spontaneous case was reported by a non-health professional and describes the occurrence of DEATH (Death) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Reported Cause(s) of Death: Unknown cause of death
Fainting (laid head on table) within seconds after vaccine administration.  Assessed and aroused patient. Took blood pressure, put cool wet towels on neck, kept patient alert and put in supine position with legs elevated on chair.  Continued to monitor blood pressure and when able to sit up was given food and water. Patient was observed for approximately 1 hour
felt achy & feverish;same day of vax pt devel hives in patches on calves, then on face, arm, jaw line, back, upper chest & tops of hands, which were described as itchy;also hot flashes;pt room mate stated pt face looked flushed & eyes red;
vaccine was injected close to the shoulder area. it was injected about 1inch above the suggested site. Pt got sore arm and got a bruise.
high pitched screaming in excess of 3 hrs; no treatment x/Tempra of 4 hrs & cool wet compresses applied @ site of inject;
Hives on face and both feet, quarter sized redness and lump at injection site, irritable, afebrile, BENADRYL 5 ml.
This is a spontaneous report from a contactable pharmacist based on information received by Pfizer from Merck & Co, Inc. (Manufacturer control number: 1-14185936048). A 60-year-old female patient received PREVNAR 13 on an unspecified date, at single dose, for immunization. The patient history was not reported. The patient's concomitant medications were not reported. On an unspecified date after vaccination, the patient experienced a 'bad reaction' for the next two weeks as she felt sick with a fever and did not feel well overall after she had a reaction to the diphtheria protein in pneumococcal 13-val conj vac (dipht crm197 protein). Events outcome was unknown. Follow-up (27APR2016): Follow-up attempts are completed. No further information is expected.
Dose administered after use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date). On 06-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Patient had a syncope episode along with nausea, backpain, and a headache after receiving the flu vaccine.  Patient was given juice and observed.  The patient's symptoms worsened.  The patient was laid down and vital signs were taken.  The patient's blood pressure, heart rate, and respiratory rate were elevated.  EMS called and patient transported to the hospital.
swollen, achey arm, fever, weakness, swollen glands under armpits for the duration of 2-3 days; took APAP, Motrin; a few days later had flu for 3 days w/fever, cold, cough; took APAP over the counter cold med
Red, patchy rash on Right thigh. Hard lump developed on 4/13/20. 2 inches in length, less than an inch in diameter
This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 50-year-old female patient who received SHINGRIX (batch number 02344621A, expiry date 20th June 2019) for prophylaxis. On 9th September 2018, the patient received the 1st dose of SHINGRIX. On 10th September 2018, 1 days after receiving SHINGRIX, the patient experienced influenza-like symptoms, dizziness and nausea. On 12th September 2018, the outcome of the influenza-like symptoms, dizziness and nausea were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, dizziness and nausea to be related to SHINGRIX. Additional details were reported as follows: The healthcare professional stated 24 hours later the patient complained of flu like symptoms, light headedness, dizziness, and nausea. The healthcare professional stated these symptoms resolved in 48 hours. The reporter consented to follow up. A clarification request was sent for the batch number.
pain and swelling in upper arm and shoulder area along with severe headaches. since within 24 hours of second shot.
Shingles; Blisters on back and shoulders; (Rash) Burning; (Rash) Itching; Rash (on back and shoulders); (Rash) Aching; (Rash) Painful; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning) and PRURITUS ((Rash) Itching) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles (The Patient had Shingles before in the1990s.) in 1990.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). In February 2021, the patient experienced RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful). At the time of the report, HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This is a spontaneous report from a contactable consumer. A patient of unspecified age, ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. The medical history and concomitant medications were not reported. The patient experienced cough and sneeze on an unspecified date with outcome of unknown. patient stated "I did have the pneumococcal 13-val conj vac (dipht crm197 protein) last week when I was at the doctor. After that, all I did was cough and sneeze for 4 days".
This spontaneous report as received from an office administer (also reported as an office manager) refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was reported. On 11-JUL-2016, the patient was vaccinated with an improperly stored (the call was because of a data logger, lowest reached temperature: 32 Fahrenheit degrees, time frame: 57 hours) dose of GARDASIL 9 lot # M003659 expiration 20-SEP-2017, intramuscular (dose and anatomical location were not reported). There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient states the night after receiving his Flu and Pneumonia vaccines he experienced nausea, vomiting, and fever.
Sore arm; This case was reported by a consumer and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (patient's husband had a terrible case of shingles, still had pain 21 months later). Previously administered products included shingles vaccine with an associated reaction of pain in extremity (received first dose on an unknown date and experienced sore arm, refer case US2021AMR226597). Concurrent medical conditions included fibromyalgia.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the second shingle shot with no side effects except a sore arm.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR226600:Same reporter US-GLAXOSMITHKLINE-US2021AMR226597:Same reporter
Severe, persistent migraine.  Menstrual cycle seriously changed - heavier, very painful.  Fatigue.
The symptoms changed day after day. The day after inoculation, my symptoms were like full COVID with body aches, fever, loss of appetite, headache and a slight brush fire feeling in my lungs. It was not severe pain, but it felt like my lungs were fighting off something. I had severe fatigue. Starting the next day, the symptoms reduced by 75% but the next few days, the low activity and body ache remained. I still had the discomfort. I took ROBITUSSIN DM and vitamin C-500mg. I also took quercetin over the counter. On Friday I started to get lower intestinal pain. On a scale of 1 to 10, the pain was a 9. I took ibuprofen 200mg for 3 nights in a row to stop the abdominal pain. I started to get minor loose bowels on Friday night. I tested myself for COVID-19 on Saturday and was negative. On Tuesday I went in to see my doctor and he diagnosed me with COVID-19 reinfection due to the booster. The previous experience with COVID was the BA5 version. My booster was the Omicron variant therefore it reactivated the previous infection. At the time when I went to the provider, I was running a fever of 99.7. I developed on Wednesday October 12, 2022. Starting Friday October 14, I developed chills which lasted for 4 days but have since subsided. I had the fever most recently on yesterday. The doctor gave me a steroid injection and a prescription for an azithromycin tablet to prevent infection or damage to major organs. I resumed taking the vitamin C and he also gave me an inhaler called TRELEGY ELLIPTA once daily. I began the treatment on yesterday. Today my symptoms are dramatically better with 90% improvement. No more fatigue no more body. Lung a little better. I do not feel that I have completely recovered as I am still feeling a little clutter that causes an occasional cough and shortness of breath.
first dose in 2018, second not administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date in 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 20-APR-2022 Reporter's Comments: Pharmacist reported a patient receiving the first dose of Shingrix on 2018 and the second dose was not administered yet.  That was all the information that the health care professional (HCP) had.  Patient was vaccinated in another facility.  The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Note: details pertains to 1st dose of Shingrix in product tab.